生长抑素受体显像与肿瘤的诊断和治疗
摘要
受体和配体的结合具有高度的特异性和组织专一性 ,研究发现多种肿瘤组织表达高密度的生长抑素受体 (SSTR) ,放射性核素标记的生长抑素可以与肿瘤细胞膜上的生长抑素受体特异性结合 ,通过放射性核素的介导作用对肿瘤进行定位和诊断。
出处
《国外医学（肿瘤学分册）》
2004年第3期195-198,共4页
Foreign Medical Sciences (Cancer Section)
参考文献13
-
1Gibril F, Reynolds JC, Chen CC, et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med, 1999, 40(3) :539-553.
-
2Kwekkeboom DJ, de Herder WW, Krenning EP. Receptor imaging in the diagnosis and treatment of pituitary tumors. J Endocrinol Invest, 1999, 22( 1 ) : 80-88.
-
3Duet M, Ajzenberg C, Benelhadj S, et al. Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivoJ. J Nucl Med, 1999, 40(6) : 1252-1256.
-
4Meijer WG, van der Veer E, Jager PL, et al. Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. J Nucl Med, 2003, 44(2) : 184-191.
-
5Gibril F, Reynolds JC, Lubensky IA, et al. Ability of somatostatin receptors scintigraphy to identify patients with gastric carcinoid: a prospective study. J Nucl Med, 2000, 41 (10) : 1646-1656.
-
6Haslinghuis LM, Krenning EP, De Herder WW, et al. Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest, 2001, 24(6) :415-422.
-
7Vaccarili M, Lococo A, Fabiani F, et al. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer.Tumori, 2000, 86(3):224-228.
-
8Bohuslavizki KH. Somatostatin receptor imaging: current status and future perspectives. J Nucl Med, 2001, 42(7):1057-1058.
-
9Bltwn JE, Handmarker H, Rinne NA. The utility of a somatostatintype receptor binding peptide radiophannaceutical (P829) in the evaluation of solitary pulmonary nodules. Chest, 1999, 115( 1):224-232.
-
10Lugtenburg PJ, Lowenberg B, Valkema R, et al. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin lymphomas. J Nucl Med, 2001, 42(2) :222-229.
-
1刘欣,王秀问.生长抑素和生长抑素受体与肺癌[J].国际肿瘤学杂志,2006,33(5):363-366. 被引量：1
-
2杨敬茂,赵钧生,王晓燕.Wnt和Notch信号通路在乳腺癌和乳腺癌干细胞中的作用[J].中国保健营养（下半月）,2013,0(2):45-45.
-
3邢加强,张百江,宋平平.生长抑素及其类似物在肺癌诊断中的应用[J].中国肺癌杂志,2007,10(3):256-258. 被引量：1
-
4陈从新.肝脏病中CD95介导的细胞凋亡[J].肝脏,1999,4(1):27-28.
-
5内辐射治癌用玻璃微球[J].科技开发动态,2004(10):61-61.
-
6周晓东,陈红霞,关润年,吕农华.Akt的活化对胃癌血管新生的促进作用[J].世界华人消化杂志,2011,19(7):744-748. 被引量：5
-
7冯青杰,闫世军,孙立群,吴东辉.抗人喉癌/抗CD_3双功能抗体的制备及对Hep-2细胞株的杀伤作用[J].中国免疫学杂志,2003,19(5):359-360.
-
8吕高波,赵阳.HBx和c-Src对肝癌细胞HepG2上皮间质转化的介导作用及其分子机制[J].山西医科大学学报,2015,46(12):1163-1168. 被引量：2
-
9梁萍,董宝玮,龙丽娟,金小海,田嘉禾,王凡,李俊来,苏莉,王向东.钇－90玻璃微球内辐射治疗肝癌的动物试验及临床研究[J].中国超声医学杂志,1995,11(4):243-246. 被引量：9
-
10杨冬华.抗体介导的肝癌靶向治疗现状及展望[J].中华肝脏病杂志,2005,13(5):380-381. 被引量：3
